SCHEMBL24725804

SCHEMBL24725804

c1ccc2c(c1)OC(c1ccc3[nH]nnc3c1)O2

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24179259 0.81 NPC1 (0.41) —
SCHEMBL22281824 0.71 NPC1 (0.44) —
SCHEMBL10948259 0.69 BACE1 (0.43) —
Benzotriazole SCHEMBL28258951 0.68 ALDH1A1 (0.39) —
SCHEMBL31110437 0.68 QDPR (0.47) —
SCHEMBL366171 0.67 CLK2 (0.49) —
Hydrochloric Acid SCHEMBL31110482 0.67 QDPR (0.46) —
SCHEMBL19640293 0.67 CLK1 (0.34) —
Benzotriazole SCHEMBL8956 0.66 — —
Benzotriazole SCHEMBL6088869 0.66 ALDH1A1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220306604-A1 CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS AMGEN INC. (US) 2022-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306604-A1 CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS TRPV1, SCN7A, TRPA1 NISCH 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback